Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 6 of 6 for “"Undruggable Target"”.

  1. Synthesis and biological characterisation of cyclic peptide PROTACs of hypoxia inducible factor 1 alpha

    PROteolytic TArgeting Chimeras (PROTACs) are heterobifunctional chemical modalities that exploit the ubiquitin proteasome system (UPS) to degrade protein targets, including those considered ‘undruggable’. Despite the success of small molecule PROTACs, the application of cyclic peptides as targeting …

    soton Download PDF for Synthesis and biological characterisation of cyclic peptide PROTACs of hypoxia inducible factor 1 alpha (opens in a new tab)

  2. Development of Allosteric Non-covalent KRAS Inhibitors that Disrupt Effector Binding and Development of Small Molecule Inhibitors to Modulate Liver X Receptor Activity

    … small molecule drug for a specific biological target mainly derives from two sources: natural products or synthetic collections of molecules. A traditional drug-like molecule can be an effective enzyme inhibitor and allosteric modifier or can target extracellular proteins or intracellular …

    houston Repository record for Development of Allosteric Non-covalent KRAS Inhibitors that Disrupt Effector Binding and Development of Small Molecule Inhibitors to Modulate Liver X Receptor Activity (opens in a new tab)

  3. Engineering Carriers for Therapeutic Protein Delivery to Intracellular Targets

    … membrane and are restricted to extracellular targets in the bloodstream or on the surface of cells. At the same time, many diseases could be treated by delivery of these proteins to certain intracellular targets which have long been considered undruggable by traditional small molecule …

    gatech Repository record for Engineering Carriers for Therapeutic Protein Delivery to Intracellular Targets (opens in a new tab)

  4. Photoaffinity labelling for the study of ligand-protein interactions

    … led to a vast increase in the number of protein targets that are known to be associated with human disease. Modulation of a protein offers the potential for a therapeutic strategy to treat the disease. However, the validation of these targets can prove challenging due to the limited portion of …

    strathclyde Repository record for Photoaffinity labelling for the study of ligand-protein interactions (opens in a new tab)

  5. Discovery of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.

    … and activation of stem-like cancer cells. Direct targeting of β‐catenin, the central hub in this signaling pathway, is a promising strategy to suppress the hyperactive β‐catenin signaling but has proven to be highlychallenging. Substantial efforts have been made to discover compounds that bind …

    usf Repository record for Discovery of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction. (opens in a new tab)

  6. Development of a Novel STAT3 Inhibitor for the Treatment and Chemoprevention of Lung Cancer

    … patients who would respond to EGFR-directed targeted therapy but only 10% of the patient population harbor those mutations. In spite of the initial benefits observed in patients receiving EGFR tyrosine kinase inhibitors as first or second line therapy, resistance develops in more than 50% of …

    umn Repository record for Development of a Novel STAT3 Inhibitor for the Treatment and Chemoprevention of Lung Cancer (opens in a new tab)